Lv11
40 积分 2022-01-11 加入
Challenges and future of HER2-positive gastric cancer therapy
12分钟前
待确认
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
14分钟前
已完结
ACG Clinical Guideline Update: Ulcerative Colitis in Adults
1个月前
已完结
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
1个月前
已完结
DOP052 Etrasimod as induction and maintenance therapy in Asian patients with moderately to severely active Ulcerative Colitis: Results from the maintenance period of a randomised, double-blind, placebo-controlled, multi-centre Phase 3 study (ES101002)
1个月前
已完结
Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project
4个月前
已完结
MET overexpression correlated with prognosis of EGFR-mutant treatment‑naïve advanced lung adenocarcinoma: a real‑world retrospective study
5个月前
已完结
Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer
6个月前
已完结
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
8个月前
已完结
First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status
8个月前
已完结
皖公网安备34019202002308
